Catalyst Advisors is a global recruiting firm specializing in finding board members, CEOs and senior functional, technical and commercial leaders for biopharmaceutical and other life sciences enterprises at all points of growth.
We are pleased to announce that Arnaldo De Lisio has joined Catalyst Advisors as a Partner in our London office. Arnaldo, who is fluent in English, Italian and German, brings deep experience working with clients to build boards and leadership teams in innovative areas of medicine, including immuno-oncology, oncology and rare diseases. Arnaldo joining the firm is the first step of a long-term plan to expand our global footprint.
For early-stage biopharma companies, having the right management team is just as important—if not more so—than investors and capital. Catalyst Advisors' Stephen J. Williams, Ph.D., walks through the common pitfalls and best practices around this critical task.
When a biopharma firm makes the jump from clinical to commercial, the board often brings in a new CEO with experience in navigating the new demands this evolution brings. Recruitment industry news source Hunt Scanlon takes a look at how Catalyst Advisors worked with three such biopharma companies to land the right chief executive.
Connect with us on LinkedIn
for our latest perspectives on biopharma leadership trends
and industry developments